Dishman to make API for Janssen; CPhI award winner finalists announced; Ashland to split;

> Ashland Chemical will divide into two publicly traded companies, one that will manufacture chemicals for pharma and other industries and one that will sell its Valvoline engine products. Release

> India's Dishman Pharmaceuticals and Chemicals said it has been selected by Johnson & Johnson's ($JNJ) Janssen Pharmaceutical to produce the active ingredient for its TB drug Sirturo. Report

> CPhI Worldwide has named the finalists in 7 categories for its annual Pharma Awards, including Catalent ($CTLT), TraceLink, Codexis and others, with winners to be selected Oct. 13 during the annual meeting this year in Madrid. Release

> Nigerian officials have said if they can get an investment of $3 million to $5 million, the country has the capability of producing Coralmyn, the antivenom for coral snake bites that is in short supply. Report